Radiation Dermatitis Clinical Trial
Official title:
Utilization of Low Level Laser Therapy for Radiation Induced Dermatitis in Patients With Head and Neck Squamous Cell Carcinoma
This study will assess the efficacy of LLLT to mitigate and ameliorate the acneiform-rash, radiation dermatitis, and pain, while assessing its impact on patient reported quality of life.
This single-arm phase I/II study establishes the safety and efficacy of low level laser therapy (LLLT) in order to mitigate radiation-induced dermatitis in patients underoing radiation therapy for head and neck squamous cell carcinoma (HNSCC). Additional objectives include assessment of patient-reported quality of life data, pain parameters and dermatologic quality of life responses. The target population is patients with histologically proven squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx or larynx who are candidates for either definitive or adjuvant therapy consisting of a chemotherapy regimen and concurrent radiation therapy. Patients are required to have a favorable performance status (KPS greater than or equal to 70), have had no prior head and neck radiotherapy and be at least 18 years of age and able to provide consent. While receiving radiotherapy and a concurrent systemic regimen, patients will receive LLLT using a 69 diode probe with dual 660 nm and 850 nm wavelengths to at least nine treatment sites in the head and neck region for a duration of 60 seconds to each site. LLLT will be given three times in a week prior to, daily during the first week of, and at least twice weekly thereafter during radiotherapy. Information collected includes toxicity scoring and quality of life surveys. A retrospective matched-pair design will be used to assess the rate of grade III complications compared to patients treated previously without LLLT support, with an anticipated 20% reduction in the risk of grade III dermatitis. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04059809 -
Photobiomodulation for Breast Cancer Radiodermatitis
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06040983 -
Clinical Investigation on the Treatment of Radiation Induced Dermatitis With FR-101 Chest Dressing
|
N/A | |
Withdrawn |
NCT05505214 -
Topical Steroids & Bacterial Decolonization for Radiation Dermatitis
|
Phase 2 | |
Withdrawn |
NCT04593914 -
A Novel Skin Barrier Protectant for Acute Radiodermatitis
|
N/A | |
Completed |
NCT05450848 -
StrataXRT vs. Standard Clinical Practice in the Prevention and Treatment of Radiation Dermatitis
|
N/A | |
Active, not recruiting |
NCT05594498 -
A Study of StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer Patients
|
N/A | |
Recruiting |
NCT04110977 -
A Reminder App to Reduce Radiation Dermatitis Rates in Patients With Head-and-Neck Cancer
|
N/A | |
Recruiting |
NCT06158347 -
Efficacy and Safety of Hyperbaric Oxygen Therapy for Radiation Dermatitis in Patients With Localized Breast Cancer
|
N/A | |
Recruiting |
NCT05553392 -
StrataXRT Versus Aquaphor for the Prevention and Management of Radiation Dermatitis
|
N/A | |
Active, not recruiting |
NCT04268056 -
Characterization of Skin Microbiome Profile and it's Correlation to Radiation Dermatitis
|
||
Not yet recruiting |
NCT04888234 -
Evaluation the Effectiveness of Ru-Yi-Jin-Huang Powder for the Radiation-induced Dermatitis.
|
Phase 2 | |
Terminated |
NCT01597921 -
A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer
|
N/A | |
Completed |
NCT00481884 -
Comparing RadiaPlexRx Hydrogel and Standard-of-Care for Radiation Dermatitis in Breast Cancer Patients
|
Phase 3 | |
Completed |
NCT03494205 -
Urtica Comp. Gel for Prevention and Therapy of Radiation Dermatitis
|
Phase 2 | |
Completed |
NCT05810194 -
Retrospective Cohort Study Comparing a Novel Gel Dressing vs SoC in the Treatment of Radiation Dermatitis
|
||
Completed |
NCT03941665 -
Use of Gelronate Gel vs. Aloevera in Preventing/Minimizing Radiation-induced Dermatitis in Breast Cancer Patients
|
N/A | |
Not yet recruiting |
NCT02051907 -
Clinical Study to Evaluate Safety and Efficacy of KAM1403 Gel to Treat Radiation Dermatitis
|
Phase 2 | |
Completed |
NCT02839473 -
Hydrosorb® Versus Control in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial
|
Phase 3 | |
Completed |
NCT00573365 -
LED Photomodulation for Prevention of Post-Radiation Treatment Dermatitis
|
N/A | |
Completed |
NCT00876642 -
Trial Comparing Best Supportive Care to Aloe Vera Gel
|
Phase 3 |